AUGMEDIX INC. - COMMON STOCK

Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue

05 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation

13 Dec 2023 10:05:24 By Nasdaq GlobeNewswire

Augmedix Announces Closing of Public Offering of Common Stock, Including Additional Investments from HCA Healthcare and Redmile Group

21 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Augmedix Announces Pricing of Upsized Public Offering of 6,250,000 Shares of Common Stock

16 Nov 2023 00:15:03 By Nasdaq GlobeNewswire

Augmedix Announces Proposed Public Offering of 5,500,000 Shares of Common Stock

15 Nov 2023 16:02:29 By Nasdaq GlobeNewswire

Augmedix Delivers 50% Revenue Growth and Expanded Gross Margins for Third Quarter of 2023

06 Nov 2023 16:02:00 By Nasdaq GlobeNewswire

Augmedix to Announce Third Quarter 2023 Financial Results and Host Investor Conference Call on November 6, 2023

30 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Augmedix Forging Strategic Partnerships for an Open Network of Digital Health Solutions

05 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Augmedix Announces New AI Medical Documentation Product, Augmedix Go, a Clinician-Controlled Mobile App

27 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

Augmedix Announces Inaugural AI Advisory Council Members

21 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

Augmedix Announces Expanding Coverage in Behavioral Health Field for Acute and Ambulatory Care Settings

06 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

Augmedix Achieves HITRUST Certification to Further Mitigate Risk in Third-Party Privacy, Security and Compliance

24 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

Augmedix Announces Participation in Upcoming Investor Conferences in September 2023

18 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

Augmedix Delivers 47% Revenue Growth and Expanded Gross Margins for Second Quarter of 2023

07 Aug 2023 16:02:00 By Nasdaq GlobeNewswire

Augmedix to Announce Second Quarter 2023 Financial Results and Host Investor Conference Call on August 7, 2023

28 Jul 2023 07:00:00 By Nasdaq GlobeNewswire

Augmedix Extends Term Loan Facility and Finalizes Terms for Equity Line of Credit

14 Jun 2023 07:05:00 By Nasdaq GlobeNewswire

Augmedix Establishes AI Advisory Council to Guide the Company’s Continued Development of High Standard, Responsible Product Development

12 Jun 2023 07:00:00 By Nasdaq GlobeNewswire

Augmedix Announces Participation in Upcoming Investor Conferences

19 May 2023 08:24:05 By Nasdaq GlobeNewswire

Augmedix Delivers Continued Sales Momentum; Reports First Quarter 2023 Financial Results

12 May 2023 07:00:00 By Nasdaq GlobeNewswire

Augmedix to Announce First Quarter 2023 Financial Results and Host Investor Conference Call on May 12, 2023

08 May 2023 07:00:00 By Nasdaq GlobeNewswire